drug
lonvoguran
Phase 3updated 5mo agoby $NTLA Intellia Therapeutics, Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Pharvaris' latest phase 3 win builds case for HAE drug with FDA verdict pendingPharvaris’ deucrictibant has tasted success in a second phase 3 study, strengthening the case for the therapy to treat hereditary angioedema patients as the Swiss biotech awaits an FDA approval dec…fiercebiotech · 20d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that